Hologic Makes Good On Mobidiag Acquisition With Expanded Launch Of Diagnostics Platform

Following the purchase of Mobidiag, Hologic has aggressively launched the Novodiag platform across Europe in a bid to dominate the local molecular diagnostics market.  

Alamy

Hologic has expanded the sales region of the Novodiag molecular diagnostic system to encompass a broader range of customers within Europe after it acquired Novodag's developer, Mobidiag.

Hologic announced plans to acquire the Finland-based molecular diagnostic company for $795m in April. The deal closed in June

More from In Vitro Diagnostics

More from Diagnostics